Latest news
The FDA Approved A New Drug For Narcolepsy. Here’s Why Patients Call It ‘Historic’ - ForbesForbes · Mon, 10 Aug 2026 20:39:59 GMTFDA Approves Orzeyful, First Drug Targeting Underlying Cause of Narcolepsy - Drug TopicsDrug Topics · Thu, 06 Aug 2026 13:44:14 GMTTakeda (NYSE: TAK) gets FDA OK for ORZEYFUL narcolepsy therapy - Stock TitanStock Titan · Thu, 06 Aug 2026 10:05:55 GMTUS FDA approves Takeda's sleep disorder pill - ReutersReuters · Wed, 05 Aug 2026 22:48:03 GMTU.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 - Business WireBusiness Wire · Wed, 05 Aug 2026 22:10:00 GMT